[(1,1-dioxidotetrahydrothien-3-yl)amino]acetic acid, 95.0%, 25mg

N-Methyl-1-(2-(methylthio)pyrimidin-4-yl)methanamine hydrochloride, 97.0%, 100mg

2,4-DIFLUOROBENZENE-1,3-DIOL, 95.0%, 250mg

1-(4,4-DIFLUOROCYCLOHEXYL)ETHANONE, 95.0%, 1g

(1S,2S)-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol, 95.0%, 500g

(R)-3H-Spiro[benzofuran-2,4'-piperidin]-3-amine dihydrochloride, 98%, 1g

2,7-Dimethylquinoline, 95.0%, 5g

1-Methylisoquinoline-3-carbaldehyde, 95+%, 100mg

Ethyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate, 95.0%, 5g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP), 25mL, >=99%, pour la synthèse peptidique

[1,2,4]triazolo[1,5-a][1,3,5]triazin-7(6H)-one, 95.0%, 10g

2-Amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-1H-purin-6(9H)-one, 98%, 25g

1H-Indazole-5-boronic acid, 97.0%, 1g